These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 20147814

  • 21. Safety of oral bisphosphonates: controlled studies on alveolar bone.
    Jeffcoat MK.
    Int J Oral Maxillofac Implants; 2006; 21(3):349-53. PubMed ID: 16796276
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers.
    Fleisher KE, Welch G, Kottal S, Craig RG, Saxena D, Glickman RS.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):509-16. PubMed ID: 20674404
    [Abstract] [Full Text] [Related]

  • 24. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
    Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA.
    J Clin Oncol; 2005 Dec 01; 23(34):8580-7. PubMed ID: 16314620
    [Abstract] [Full Text] [Related]

  • 25. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA.
    J Oral Maxillofac Surg; 2009 May 01; 67(5 Suppl):35-43. PubMed ID: 19371813
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients.
    Walter C, Al-Nawas B, du Bois A, Buch L, Harter P, Grötz KA.
    Cancer; 2009 Apr 15; 115(8):1631-7. PubMed ID: 19156913
    [Abstract] [Full Text] [Related]

  • 28. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C, Al-Nawas B, Grötz KA, Thomas C, Thüroff JW, Zinser V, Gamm H, Beck J, Wagner W.
    Eur Urol; 2008 Nov 15; 54(5):1066-72. PubMed ID: 18602738
    [Abstract] [Full Text] [Related]

  • 29. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.
    Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N.
    J Oral Maxillofac Surg; 2009 Apr 15; 67(4):850-5. PubMed ID: 19304045
    [Abstract] [Full Text] [Related]

  • 30. Editorial opinion versus real data and knowledge of the literature.
    Marx RE.
    Int J Oral Maxillofac Implants; 2008 Apr 15; 23(4):587-8. PubMed ID: 18807554
    [No Abstract] [Full Text] [Related]

  • 31. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT, Amenedo C, Freeman K, Kraut RA.
    J Oral Maxillofac Surg; 2008 Feb 15; 66(2):223-30. PubMed ID: 18201600
    [Abstract] [Full Text] [Related]

  • 32. Surgical management of bisphosphonate induced osteonecrosis of the jaws.
    Williamson RA.
    Int J Oral Maxillofac Surg; 2010 Mar 15; 39(3):251-5. PubMed ID: 20015614
    [Abstract] [Full Text] [Related]

  • 33. Bisphosphonates--what the dentist needs to know: practical considerations.
    Fantasia JE.
    J Oral Maxillofac Surg; 2009 May 15; 67(5 Suppl):53-60. PubMed ID: 19371815
    [No Abstract] [Full Text] [Related]

  • 34. Osteonecrosis of the jaw and biomarkers: what do we tell our patients?
    Koka S.
    Int J Oral Maxillofac Implants; 2008 May 15; 23(2):179-80. PubMed ID: 18548914
    [No Abstract] [Full Text] [Related]

  • 35. Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis?
    Zavras AI, Zhu S.
    J Oral Maxillofac Surg; 2006 Jun 15; 64(6):917-23. PubMed ID: 16713806
    [Abstract] [Full Text] [Related]

  • 36. Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the bone.
    Cremers S, Farooki A.
    Ann N Y Acad Sci; 2011 Feb 15; 1218():80-7. PubMed ID: 20946577
    [Abstract] [Full Text] [Related]

  • 37. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
    Vescovi P, Nammour S.
    Minerva Stomatol; 2010 Apr 15; 59(4):181-203, 204-13. PubMed ID: 20360666
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER, Basile JD.
    J Oral Maxillofac Surg; 2009 May 15; 67(5 Suppl):85-95. PubMed ID: 19371819
    [Abstract] [Full Text] [Related]

  • 40. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
    Dodson TB.
    J Oral Maxillofac Surg; 2009 May 15; 67(5 Suppl):44-52. PubMed ID: 19371814
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.